https://www.selleckchem.com/pr....oducts/wortmannin.ht
05) as well as in patients with severe form compared to moderate and mild forms of VUR (P .05 and P .05, respectively). Also, ROC analysis revealed the sensitivity of 61% and specificity of 53% for uNGAL/uCr ratio for prediction of VUR. Our findings indicate a potential predictive value of uNGAL/uCr ratio as a non-invasive biomarker for the management of VUR although, its clinical application has been challenging and needs to be confirmed by further investigations. Our findings indicate a potential predictive value of uNGAL